✦ LIBER ✦

218 Phase II study of bi-weekly paclitaxel (P) and cisplatin (C) for non-resectable non small-cell lung cancer (NSCLC)

✍ Scribed by Sørensen, J.B.; Wedervang, K.; Hansen, H.H.; Dombernowsky, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly treatment of non-small-cell lung

✍ Schroeder, M.; Ukena, D.; Schütte, W.; Schröder, R.; Westerhausen, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Phase I/II study of paclitaxel/vinorelbi

✍ Grunberg, S.M; Greenblatt, M; Ospina, D; Valentine, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase I/II study of concurrent twice-wee

✍ Solomon, B.; Ball, D.L.; Richardson, G.; Smith, J.G.; Millward, M.; MacManus, M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Concurrent radiation and weekly cisplati

✍ Raymond P. Abratt; Paul A. Willcox; D. G. Mame Salton 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 299 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase I/II study of cisplatin combined w

✍ Yoshimura, N; Kudoh, S; Mukohara, T; Yamauchi, S; Yamada, M; Kawaguchi, T; Nakao 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB